Search research articles
Contact Us
Filters
Showing results (401-410 of 451) with videos related to
Page
of 46
Sort By:
Neuro-Oncology
|
April 18, 2025
Molecular signatures define BAP1-altered meningioma as a distinct CNS tumor with deregulation of Polycomb repressive complex target genes
Philipp Sievers, Sonali Arora, Thomas Hielscher, et al.
Acta Neuropathologica Communications
|
October 30, 2019
Tumors diagnosed as cerebellar glioblastoma comprise distinct molecular entities
Annekathrin Reinhardt, Damian Stichel, Daniel Schrimpf, et al.
Cell Stem Cell
|
February 12, 2025
Individualized patient tumor organoids faithfully preserve human brain tumor ecosystems and predict patient response to therapy
Tianping Peng, Xiujian Ma, Wei Hua, et al.
Neuro-Oncology
|
June 3, 2026
Primary Mismatch Repair Deficient Glioma (PMMRDG), IDH-wildtype and H3-wildtype: A Giant Cell Tumor with Potential for Long-Term Survival Occurring at all Ages
Abigail K Suwala, Dennis Friedel, Felix E Hinz, et al.
Acta Neuropathologica
|
November 26, 2025
Loss of global DNA hypermethylation is prognostic in IDH-mutant and 1p/19q-codeleted oligodendrogliomas
Felix E Hinz, Dennis Friedel, Franziska M Ippen, et al.
The Lancet. Oncology
|
September 4, 2025
The effect of TERT promoter mutation on predicting meningioma outcomes: a multi-institutional cohort analysis
Karenna J Groff, Ruchit V Patel, Yang Feng, et al.
Neuro-Oncology
|
July 22, 2025
Distinct molecular profile and outcome of oligodendroglioma, IDH-mutant, 1p/19q-codeleted and TERTp-wildtype: a grade 1 oligodendroglioma of young patients?
Filippo Nozzoli, Ramin Rahmanzade, Simone Schmid, et al.
Acta Neuropathologica Communications
|
April 5, 2024
CNS tumors with PLAGL1-fusion: beyond ZFTA and YAP1 in the genetic spectrum of supratentorial ependymomas
Arnault Tauziède-Espariat, Yvan Nicaise, Philipp Sievers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 25, 2020
Nonmetastatic Medulloblastoma of Early Childhood: Results From the Prospective Clinical Trial HIT-2000 and An Extended Validation Cohort
Martin Mynarek, Katja von Hoff, Torsten Pietsch, et al.
Cancer Discovery
|
March 20, 2021
ZFTA-RELA Dictates Oncogenic Transcriptional Programs to Drive Aggressive Supratentorial Ependymoma
Amir Arabzade, Yanhua Zhao, Srinidhi Varadharajan, et al.
Page
of 46
Search research articles
Search
Showing results (401-410 of 451) with videos related to
Sort By:
Page
of 46
Neuro-Oncology
|
April 18, 2025
Molecular signatures define BAP1-altered meningioma as a distinct CNS tumor with deregulation of Polycomb repressive complex target genes
Philipp Sievers, Sonali Arora, Thomas Hielscher, et al.
Acta Neuropathologica Communications
|
October 30, 2019
Tumors diagnosed as cerebellar glioblastoma comprise distinct molecular entities
Annekathrin Reinhardt, Damian Stichel, Daniel Schrimpf, et al.
Cell Stem Cell
|
February 12, 2025
Individualized patient tumor organoids faithfully preserve human brain tumor ecosystems and predict patient response to therapy
Tianping Peng, Xiujian Ma, Wei Hua, et al.
Neuro-Oncology
|
June 3, 2026
Primary Mismatch Repair Deficient Glioma (PMMRDG), IDH-wildtype and H3-wildtype: A Giant Cell Tumor with Potential for Long-Term Survival Occurring at all Ages
Abigail K Suwala, Dennis Friedel, Felix E Hinz, et al.
Acta Neuropathologica
|
November 26, 2025
Loss of global DNA hypermethylation is prognostic in IDH-mutant and 1p/19q-codeleted oligodendrogliomas
Felix E Hinz, Dennis Friedel, Franziska M Ippen, et al.
The Lancet. Oncology
|
September 4, 2025
The effect of TERT promoter mutation on predicting meningioma outcomes: a multi-institutional cohort analysis
Karenna J Groff, Ruchit V Patel, Yang Feng, et al.
Neuro-Oncology
|
July 22, 2025
Distinct molecular profile and outcome of oligodendroglioma, IDH-mutant, 1p/19q-codeleted and TERTp-wildtype: a grade 1 oligodendroglioma of young patients?
Filippo Nozzoli, Ramin Rahmanzade, Simone Schmid, et al.
Acta Neuropathologica Communications
|
April 5, 2024
CNS tumors with PLAGL1-fusion: beyond ZFTA and YAP1 in the genetic spectrum of supratentorial ependymomas
Arnault Tauziède-Espariat, Yvan Nicaise, Philipp Sievers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 25, 2020
Nonmetastatic Medulloblastoma of Early Childhood: Results From the Prospective Clinical Trial HIT-2000 and An Extended Validation Cohort
Martin Mynarek, Katja von Hoff, Torsten Pietsch, et al.
Cancer Discovery
|
March 20, 2021
ZFTA-RELA Dictates Oncogenic Transcriptional Programs to Drive Aggressive Supratentorial Ependymoma
Amir Arabzade, Yanhua Zhao, Srinidhi Varadharajan, et al.
Page
of 46